Please use this identifier to cite or link to this item: http://nopr.niscpr.res.in/handle/123456789/9213
Full metadata record
DC FieldValueLanguage
dc.contributor.authorDogan, H Nese-
dc.contributor.authorDuran, Arzu-
dc.contributor.authorRollas, Sevim-
dc.date.accessioned2010-06-01T04:44:02Z-
dc.date.available2010-06-01T04:44:02Z-
dc.date.issued2005-11-
dc.identifier.issn0975-0983(Online); 0376-4699(Print)-
dc.identifier.urihttp://hdl.handle.net/123456789/9213-
dc.description2301-2307en_US
dc.description.abstractThe compounds 1H-4,5-dihydro-3-(3-hydroxy-2-naphthyl)-4-substituted-1,2,4-triazoline-5-thiones have been synthesised from 3-hydroxy-2-naphthoic acid hydrazide in two steps. The structural elucidation of the synthesised compounds has been performed by 1H NMR and mass spectroscopic data besides elemental analyses. Some of the compounds are tested in vitro for their ability to inhibit growth of 60 different human cancer cell lines by the National Cancer Institute and notable cytotoxic effect on some cancer cell lines is observed from some of them as expected in comparison with the control agent 5-fluorouracil.en_US
dc.language.isoen_USen_US
dc.publisherCSIRen_US
dc.relation.ispartofseriesInt.Cl.7 C 07 D // A 61 P 35/02en_US
dc.sourceIJC-B Vol.44B(11) [November 2005]en_US
dc.subject1H-4,5-dihydro-3-(3-hydroxy-2-naphthyl)-4-substituted-1,2,4-triazoline-5-thionesen_US
dc.subjectanticancer activityen_US
dc.titleSynthesis and preliminary anticancer activity of new 1H-4,5-dihydro-3-(3-hydroxy-2-naphthyl)-4-substituted-1,2,4-triazoline-5-thiones. Part IIen_US
dc.typeArticleen_US
Appears in Collections:IJC-B Vol.44B(11) [November 2005]

Files in This Item:
File Description SizeFormat 
IJCB 44B(11) 2301-2307.pdf64.91 kBAdobe PDFView/Open


Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.